Concepedia

Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer

Sudeepta Aggarwal, Tao He, William W. Fitzhugh, Kim Rosenthal, Brian Feild, Jenny L. Heidbrink, Deborah Mesmer, Steven M. Ruben, Paul A. Moore

Gynecologic Oncology · 2009 · 33 citations · 38 references

DOI

Concepts

References

38

Probability-based protein identification by searching sequence databases using mass spectrometry data

David N. Perkins, Darryl Pappin, David M. Creasy et al. · Electrophoresis · 1999 · 8.3K citations

, , +17

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

Wataru Sakai, Elizabeth M. Swisher, Beth Y. Karlan et al. · Nature · 2008 · 1.1K citations · Full text

, , +13

Secondary <i>BRCA1</i> Mutations in <i>BRCA1</i> -Mutated Ovarian Carcinomas with Platinum Resistance

Elizabeth M. Swisher, Wataru Sakai, Beth Y. Karlan et al. · Cancer Research · 2008 · 454 citations · Full text

, , +16

Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

Muthu Selvakumaran, Debra Pisarcik, Rudi Bao et al. · PubMed · 2003 · 316 citations

, , +14

BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

Amreen Husain, Gang He, E. S. Venkatraman et al. · PubMed · 1998 · 290 citations

, , +17